Skip to content

Update on NICE Decision for Continued Access to risdiplam (Evrysdi) and nusinersen (Spinraza). 

News
Treatments & Research

First NICE committee meeting for continued access to Spinraza and Risdiplam

Advocacy
News

The Power of Real-World Data: Why Patients’ Experiences Prove the Case for SMA Drugs  

Advocacy
News

Beyond Mobility: Why Holding the Line is a Major Win in SMA Treatment

Advocacy
News

Landmark victory as Spinraza becomes routinely available on the NHS in Scotland

Advocacy
Information
News
Treatments & Research
Image shows a couple with a child in a whizzy bug holdig signs that say #ScreenTodayForSMA and SMA treatements: essential not exendable

The Scottish Government will be adding SMA to their newborn screening programme

Advocacy
News
images shows a couple with a child holding a sign that says "We need newborn screening now!"

SMA MTA External Assessment Report is now live

Advocacy
News

Government U-Turns on Key Disability Benefit Cuts After Backlash

News

Hattie and James share their son Theo’s story about his SMA diagnosis   

Advocacy
News
Treatments & Research

The National Institute for Health and Care research (NIHR) release ‘research call’

Advocacy
News